# Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis

> **NCT00578955** · PHASE3 · COMPLETED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 417 (actual)

## Conditions studied

- Blepharoconjunctivitis

## Interventions

- **DRUG:** 1% Azithromycin and 0.1% Dexamethasone
- **DRUG:** 1% Azithromycin
- **DRUG:** 0.1% Dexamethasone

## Key facts

- **NCT ID:** NCT00578955
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 417 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00578955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00578955, "Comparative Study of AzaSite Plus Compared to AzaSite Alone and Dexamethasone Alone to Treat Subjects With Blepharoconjunctivitis". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00578955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*